HomeNXGN • TLV
add
Nextgen Biomed Ltd
Previous close
ILA 61.60
Day range
ILA 56.00 - ILA 71.80
Year range
ILA 52.80 - ILA 128.60
Market cap
7.04M ILS
Avg Volume
9.30K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
(ILS) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.60M | 2.01% |
Net income | -1.59M | 73.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.56M | 0.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(ILS) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.00K | -46.15% |
Total assets | 575.00K | 120.31% |
Total liabilities | 3.04M | 145.16% |
Total equity | -2.46M | — |
Shares outstanding | 9.20M | — |
Price to book | -2.46 | — |
Return on assets | -693.48% | — |
Return on capital | 177.78% | — |
Cash Flow
Net change in cash
(ILS) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -1.59M | 73.72% |
Cash from operations | -565.00K | 43.89% |
Cash from investing | -12.50K | 90.42% |
Cash from financing | 493.00K | — |
Net change in cash | -88.50K | 92.23% |
Free cash flow | -972.19K | -88.89% |
About
Founded
1990
Website
Employees
5